• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠期糖尿病女性中沉默调节蛋白的胎盘表达

Placental Expression of Sirtuins in Women with Gestational Diabetes.

作者信息

Czerewaty Michał, Ustianowski Łukasz, Kiełbowski Kajetan, Bakinowska Estera, Safranow Krzysztof, Tarnowski Maciej, Sroczyński Tomasz, Pawlik Andrzej

机构信息

Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland.

Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70-111 Szczecin, Poland.

出版信息

Genes (Basel). 2025 Jul 20;16(7):844. doi: 10.3390/genes16070844.

DOI:10.3390/genes16070844
PMID:40725501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12294697/
Abstract

BACKGROUND/OBJECTIVES: Gestational diabetes mellitus (GDM) is a common metabolic disorder in pregnant women. It can lead to several complications, such as preterm delivery, macrosomia, or metabolic disorders in newborns. Studies have revealed morphological and transcriptional differences between the placentas of patients with GDM and women with normal glucose tolerance. Sirtuins (SIRTs) are nicotinamide adenine dinucleotide-dependent deacetylases that interact with and regulate the activity of numerous proteins. However, little is known about their role in the pathogenesis of GDM. This study was performed to analyze the placental expression of SIRTs and investigate their correlations with clinical parameters.

METHODS

GDM was diagnosed based on the 75 g oral glucose tolerance test in accordance with the criteria developed by the International Association of Diabetes and Pregnancy Study Groups. Placental tissues were collected, and the expression of and a reference gene (β-2 microglobulin) was analyzed.

RESULTS

The placental expression of and was elevated in women with GDM. However, there was no significant difference in expression between women with GDM and those with normal glucose tolerance. Furthermore, we found no significant correlations between , , and expression and clinical parameters.

CONCLUSIONS

The findings of this study demonstrate elevated expression of and in the placentas of women with GDM. Further studies are required to confirm our observations and demonstrate the precise role of these enzymes in GDM.

摘要

背景/目的:妊娠期糖尿病(GDM)是孕妇常见的代谢紊乱疾病。它可导致多种并发症,如早产、巨大儿或新生儿代谢紊乱。研究显示,GDM患者胎盘与糖耐量正常女性胎盘在形态和转录方面存在差异。沉默调节蛋白(SIRTs)是烟酰胺腺嘌呤二核苷酸依赖性脱乙酰酶,可与多种蛋白质相互作用并调节其活性。然而,它们在GDM发病机制中的作用尚不清楚。本研究旨在分析胎盘组织中SIRTs的表达情况,并探讨其与临床参数的相关性。

方法

根据国际糖尿病与妊娠研究组制定的标准,采用75g口服葡萄糖耐量试验诊断GDM。收集胎盘组织,分析[具体蛋白名称未给出]和一个参考基因(β-2微球蛋白)的表达。

结果

GDM女性胎盘组织中[具体蛋白名称未给出]和[另一具体蛋白名称未给出]的表达升高。然而,GDM女性与糖耐量正常女性的[具体蛋白名称未给出]表达无显著差异。此外,我们发现[具体蛋白名称未给出]、[另一具体蛋白名称未给出]的表达与临床参数之间无显著相关性。

结论

本研究结果表明,GDM女性胎盘组织中[具体蛋白名称未给出]和[另一具体蛋白名称未给出]的表达升高。需要进一步研究以证实我们的观察结果,并阐明这些酶在GDM中的精确作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f83/12294697/b0cc5e64693e/genes-16-00844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f83/12294697/fb6fb53145df/genes-16-00844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f83/12294697/2c4ed5a6dece/genes-16-00844-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f83/12294697/b0cc5e64693e/genes-16-00844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f83/12294697/fb6fb53145df/genes-16-00844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f83/12294697/2c4ed5a6dece/genes-16-00844-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f83/12294697/b0cc5e64693e/genes-16-00844-g003.jpg

相似文献

1
Placental Expression of Sirtuins in Women with Gestational Diabetes.妊娠期糖尿病女性中沉默调节蛋白的胎盘表达
Genes (Basel). 2025 Jul 20;16(7):844. doi: 10.3390/genes16070844.
2
Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health.基于不同风险特征和环境进行妊娠期糖尿病筛查以改善母婴健康。
Cochrane Database Syst Rev. 2017 Aug 3;8(8):CD007222. doi: 10.1002/14651858.CD007222.pub4.
3
Different strategies for diagnosing gestational diabetes to improve maternal and infant health.诊断妊娠期糖尿病以改善母婴健康的不同策略。
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD007122. doi: 10.1002/14651858.CD007122.pub4.
4
Different intensities of glycaemic control for women with gestational diabetes mellitus.不同强度的血糖控制对妊娠期糖尿病妇女的影响。
Cochrane Database Syst Rev. 2023 Oct 10;10(10):CD011624. doi: 10.1002/14651858.CD011624.pub3.
5
Diet and exercise interventions for preventing gestational diabetes mellitus.预防妊娠期糖尿病的饮食和运动干预措施。
Cochrane Database Syst Rev. 2015 Apr 12(4):CD010443. doi: 10.1002/14651858.CD010443.pub2.
6
Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.孕期女性产前补充肌醇以预防妊娠期糖尿病。
Cochrane Database Syst Rev. 2015 Dec 17;2015(12):CD011507. doi: 10.1002/14651858.CD011507.pub2.
7
Increased fractalkine expression in placental tissue and HUVECs from pregnant women with gestational diabetes mellitus and its correlation with clinicopathological variables in a case-control study.一项病例对照研究中,妊娠糖尿病孕妇胎盘组织和人脐静脉内皮细胞中趋化因子表达增加及其与临床病理变量的相关性
J Matern Fetal Neonatal Med. 2025 Dec;38(1):2534505. doi: 10.1080/14767058.2025.2534505. Epub 2025 Jul 20.
8
Different intensities of glycaemic control for women with gestational diabetes mellitus.妊娠期糖尿病女性不同强度的血糖控制
Cochrane Database Syst Rev. 2016 Apr 7;4(4):CD011624. doi: 10.1002/14651858.CD011624.pub2.
9
Insulin for the treatment of women with gestational diabetes.用于治疗妊娠期糖尿病女性的胰岛素。
Cochrane Database Syst Rev. 2017 Nov 5;11(11):CD012037. doi: 10.1002/14651858.CD012037.pub2.
10
Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes.用于患有已确诊糖尿病/糖耐量受损或既往妊娠糖尿病且计划怀孕的女性,或患有孕前糖尿病的孕妇的口服抗糖尿病药物。
Cochrane Database Syst Rev. 2017 Oct 18;10(10):CD007724. doi: 10.1002/14651858.CD007724.pub3.

本文引用的文献

1
Sirtuins and Their Implications in the Physiopathology of Gestational Diabetes Mellitus.沉默调节蛋白及其在妊娠期糖尿病生理病理学中的意义。
Pharmaceuticals (Basel). 2025 Jan 1;18(1):41. doi: 10.3390/ph18010041.
2
Metabolomic and genetic architecture of gestational diabetes subtypes.妊娠期糖尿病亚型的代谢组学和遗传结构。
Diabetologia. 2024 May;67(5):895-907. doi: 10.1007/s00125-024-06110-x. Epub 2024 Feb 17.
3
Expression and correlation analysis of silent information regulator 1 (SIRT1), sterol regulatory element-binding protein-1 (SREBP1), and pyroptosis factor in gestational diabetes mellitus.
沉默信息调节因子1(SIRT1)、固醇调节元件结合蛋白-1(SREBP1)与细胞焦亡因子在妊娠期糖尿病中的表达及相关性分析
J Matern Fetal Neonatal Med. 2024 Dec;37(1):2311809. doi: 10.1080/14767058.2024.2311809. Epub 2024 Feb 7.
4
The Role of Sirtuin-1 (SIRT1) in the Physiology and Pathophysiology of the Human Placenta.Sirtuin-1(SIRT1)在人胎盘生理学和病理生理学中的作用。
Int J Mol Sci. 2023 Nov 11;24(22):16210. doi: 10.3390/ijms242216210.
5
Effects of sirtuin 1 deficiency on trophoblasts and its implications in the pathogenesis of pre-eclampsia.Sirtuin 1 缺乏对滋养细胞的影响及其在子痫前期发病机制中的意义。
J Obstet Gynaecol. 2023 Dec;43(2):2282103. doi: 10.1080/01443615.2023.2282103. Epub 2023 Nov 15.
6
The role of sirtuins in the regulatin of oxidative stress during the progress and therapy of type 2 diabetes mellitus.Sirtuins 在 2 型糖尿病的发生和治疗过程中对氧化应激的调节作用。
Life Sci. 2023 Nov 15;333:122187. doi: 10.1016/j.lfs.2023.122187. Epub 2023 Oct 17.
7
Understanding the role of sirtuin 1 in muscle physiology during androgen deprivation.了解沉默调节蛋白1在雄激素剥夺期间肌肉生理学中的作用。
J Physiol. 2023 Nov;601(21):4659-4660. doi: 10.1113/JP285588. Epub 2023 Oct 3.
8
Placenta-derived exosomal miR-135a-5p promotes gestational diabetes mellitus pathogenesis by activating PI3K/AKT signalling pathway via SIRT1.胎盘来源的外泌体 miR-135a-5p 通过 SIRT1 激活 PI3K/AKT 信号通路促进妊娠期糖尿病发病机制。
J Cell Mol Med. 2023 Dec;27(23):3729-3743. doi: 10.1111/jcmm.17941. Epub 2023 Sep 4.
9
Sirtuin 1 is a potential therapeutic candidate gene for fetal growth restriction via insulin-like 4.Sirtuin 1 是胰岛素样生长因子 4 潜在的治疗胎儿生长受限的候选基因。
J Matern Fetal Neonatal Med. 2023 Dec;36(2):2253486. doi: 10.1080/14767058.2023.2253486.
10
Cardamonin protects against iron overload induced arthritis by attenuating ROS production and NLRP3 inflammasome activation via the SIRT1/p38MAPK signaling pathway.小豆蔻明通过 SIRT1/p38MAPK 信号通路抑制 ROS 产生和 NLRP3 炎性小体激活,从而防治铁过载诱导的关节炎。
Sci Rep. 2023 Aug 23;13(1):13744. doi: 10.1038/s41598-023-40930-y.